Search

John M Pocekay

from Martinez, CA
Age ~72
Get Report
Also known as:
John Pocekay Revocable, John Y
Phone and address:
537 Thistle Cir, Pacheco, CA 94553
Related to:
Lien V Bui, 68Karen T Nguyen, 57Jennifer S Pocekay, 72Astrid A Pocekay, 76Astr A PocekayRonald T Low, 66
Connected to:
Carl J Poch, 85Cynthia R Poch, 47Joan M Poch, 53Loretta K Poch, 67Jennifer N Pochatek, 52Margaret R Pochay, 62Charlette A Poche, 71Jarvis J Poche, 85Keith Poche, 53Terri L Poche, 55

John Pocekay Phones & Addresses

  • 537 Thistle Cir, Martinez, CA 94553
  • 921 Moraga Ave, Oakland, CA 94611 (559) 240-0613
  • Piedmont, CA
  • 2526 Gina Dr, Napa, CA 94558 (707) 255-5504
  • Newport Coast, CA
  • Chico, CA
  • Maricopa, AZ
  • Orange, CA

Work

Company: Bio-rad laboratories Jan 2003 to Jan 2014 Position: Staff scientist

Education

Degree: Masters School / High School: Creighton University 1974 to 1977 Specialities: Biology

Industries

Biotechnology

Resumes

Resumes

John Pocekay Photo 1

John Pocekay

View page
Location:
Oakland, CA
Industry:
Biotechnology
Work:
Bio-Rad Laboratories Jan 2003 - Jan 2014
Staff Scientist
Bio-Rad Laboratories Clinical Systems Division 1991 - 2003
Senior Scientist
Education:
Creighton University 1974 - 1977
Masters, Biology University of California, Davis 1968 - 1973

Publications

Us Patents

B.sub.12 Enzyme Imunoassay And Sample Pretreatment

View page
US Patent:
51871076, Feb 16, 1993
Filed:
Jun 27, 1991
Appl. No.:
7/722034
Inventors:
Michael I. Watkins - Hercules CA
Clifford R. Bartlett - Fairfield CA
Edward T. Liang - Hercules CA
John M. Pocekay - Napa CA
Mark A. Staples - Richmond CA
Assignee:
Bio-Rad Laboratories, Inc. - Hercules CA
International Classification:
G01N 33567
G01N 100
US Classification:
436505
Abstract:
Denaturing agents used to pretreat test samples for immunoassays are neutralized and deactivated by the addition of a treatment agent which is a combination of a buffering agent in acid form and an agent for converting the sulfhydryl groups of the denaturing agents to a non-active form such as disulfides or alkylthio groups. The treatment agent serves this function without having sufficient denaturing activity by itself to interfere with subsequent steps of the assay procedure. Also disclosed is a protocol for a vitamin B. sub. 12 assay which involves a sequential rather than competitive binding of the B. sub. 12 with excess intrinsic factor followed by the binding of excess enzyme-labeled B. sub. 12 to any remaining intrinsic and immobilizing such intrinsic factor on a solid phase. Various problems associated with B. sub.
Control profile
John M Pocekay from Martinez, CA, age ~72 Get Report